(Q35804392)

10 August 2017

Randomized cross-over clinical trial to study potential pharmacokinetic interactions between cisplatin or carboplatin and etoposide (English)

1 reference

10 August 2017

1 reference

1 reference

1 reference

Huw D Thomas

1

1 reference

10 August 2017

David J Porter

2

1 reference

10 August 2017

Imke Bartelink

3

1 reference

10 August 2017

Joy R Nobbs

4

1 reference

10 August 2017

Michael Cole

5

1 reference

10 August 2017

Suzie Elliott

6

1 reference

10 August 2017

David R Newell

7

1 reference

10 August 2017

A Hilary Calvert

8

1 reference

10 August 2017

Martin Highley

9

1 reference

10 August 2017

Alan V Boddy

10

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

British Journal of Clinical Pharmacology

10 August 2017

1 reference

10 August 2017

53

1 reference

10 August 2017

1

1 reference

10 August 2017

83-91

1 reference

Evaluation of synergism by a novel three-dimensional model for the combined action of cisplatin and etoposide on the growth of a human small-cell lung-cancer cell line, SBC-3.

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

Pharmacokinetically guided dosing of carboplatin and etoposide during peritoneal dialysis and haemodialysis

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung cancer: results of a North Central Cancer Treatment Group randomized clinical trial

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

Cisplatin pharmacokinetics in elderly patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

Inhibition of testicular cytochrome P-450-dependent steroid biosynthesis by cis-platinum. Reversal by human chorionic gonadotropin

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

The clinical pharmacology of etoposide and teniposide

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

Platinum anticancer drugs modulate P-450 mRNA levels and differentially alter hepatic drug and steroid hormone metabolism in male and female rats

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

Sequences of taxol and cisplatin: a phase I and pharmacologic study

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

Human cytochrome P450 metabolism of teniposide and etoposide

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

Use of etoposide in patients with organ dysfunction: pharmacokinetic and pharmacodynamic considerations

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

Antitumor activity of platinum complexes

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1874557

Effectiveness of carboplatin, etoposide, and bleomycin combination chemotherapy in good-prognosis metastatic testicular nonseminomatous germ cell tumors

25 September 2018

1 reference

12 December 2020

Pharmacokinetics of etoposide: correlation of pharmacokinetic parameters with clinical conditions

1 reference

12 December 2020

Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional study

1 reference

12 December 2020

Etoposide pharmacokinetics and pharmacodynamics after acute and chronic exposure to cisplatin

1 reference

12 December 2020

Altered etoposide pharmacokinetics and time to engraftment in pediatric patients undergoing autologous bone marrow transplantation

1 reference

12 December 2020

Therapeutic monitoring of continuous infusion etoposide in small-cell lung cancer

1 reference

12 December 2020

Etoposide phosphate infusion with therapeutic drug monitoring in combination with carboplatin dosed by area under the curve: a cancer research campaign phase I/II committee study

1 reference

12 December 2020

Role of cytochrome P-450 as a source of catalytic iron in cisplatin-induced nephrotoxicity

1 reference

12 December 2020

Pharmacokinetics of etoposide (VP16) in children and adolescents with refractory solid tumors

1 reference

12 December 2020

Interaction of etoposide and cisplatin in an in vitro tumor model

1 reference

12 December 2020

Cytochrome P-450-mediated O-demethylation: a route in the metabolic activation of etoposide (VP-16-213)

1 reference

12 December 2020

Disposition of unchanged cisplatin in patients with ovarian cancer

1 reference

12 December 2020

Lack of in vitro synergy between etoposide and cis-diamminedichloroplatinum(II)

1 reference

12 December 2020

10.1046/J.0306-5251.2001.01513.X

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

11849199

1 reference